Patients treated with datopotamab deruxtecan reported longer preservation of quality of life and physical functioning vs chemotherapy in metastatic TNBC.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/patient-reported-data-strengthen-case-dato-dxd-first-line-2026a1000f34?src=rss
Author :
Publish date : 2026-05-11 12:27:00
Copyright for syndicated content belongs to the linked Source.
